Partners
Networking
The European Society of Paediatric Infectious Diseases (ESPID) has prioritised the development of clinical trials in paediatric antimicrobials as one of its key development areas and has extensive experience in paediatric vaccination studies.
PENTA – the Paediatric European Network for the Treatment of AIDS is a very successful paediatric HIV clinical trials research network, and has worked across Europe over 15 years successfully, conducting around 15 trials including pharmacokinetic and clinical studies of paediatric antiretrovirals.
TEDDY (Task force in Europe for Drug Development in the Young), an EU-funded Network of Excellence coordinated by CVBF has developed a very effective framework to facilitate clinical trials in children.
ESPID, PENTA and TEDDY have now agreed formally to develop a new partnership called PENTi (Paediatric European Network for the Treatment of Infection) to bring together the expertise both of organisations and networks. This new network will bring together the clinical trials expertise of PENTA, working through the Medical Research Council (MRC) and INSERM-CTU, linked to the clinical paediatric infectious diseases networks that already exist across Europe through the ESPID membership.
The NeoMero project will build a structure of neonatal units across Europe that will have the clinical research expertise to develop future paediatric antimicrobial studies.
PENTA – the Paediatric European Network for the Treatment of AIDS is a very successful paediatric HIV clinical trials research network, and has worked across Europe over 15 years successfully, conducting around 15 trials including pharmacokinetic and clinical studies of paediatric antiretrovirals.
TEDDY (Task force in Europe for Drug Development in the Young), an EU-funded Network of Excellence coordinated by CVBF has developed a very effective framework to facilitate clinical trials in children.
ESPID, PENTA and TEDDY have now agreed formally to develop a new partnership called PENTi (Paediatric European Network for the Treatment of Infection) to bring together the expertise both of organisations and networks. This new network will bring together the clinical trials expertise of PENTA, working through the Medical Research Council (MRC) and INSERM-CTU, linked to the clinical paediatric infectious diseases networks that already exist across Europe through the ESPID membership.
The NeoMero project will build a structure of neonatal units across Europe that will have the clinical research expertise to develop future paediatric antimicrobial studies.
The consortium
Considering the specific focus of NeoMero on running clinical studies in neonates and infants, the Consortium is the result of a selection of strategic partners out of groups and organisations working on Paediatric Infectious Diseases and Neonatal Medicine in Europe and with expertise in running clinical trials in children.
The following main criteria guided the composition of the Consortium:
The following main criteria guided the composition of the Consortium:
- Complementarity in expertise and resources: The Consortium should harbour specific complementary expertise and/or resources necessary for the successful completion of the tasks planned in the proposal.
- Direct links to clinical sites for patients’ recruitment: The Consortium should have the clinical expertise and experience in clinical research in NICU. They also should be able to enrol the number of patients needed for the planned clinical trials.
- Direct links to external stakeholders: The Consortium should have a strategic position in research on paediatric medicine, including links with EMEA, European scientific societies (e.g. ESPID) and other relevant European networks (e.g. TEDDY, PENTA).
- Balanced geographical spread: Globally, the Consortium should have a balanced geographical spread, should be kept manageable and efficient.
- Efficiency: Because the activities in NeoMero are in part complementary to the existing coordination activities in PENTA, significant efficiencies can be achieved if use is made of the existing resources, infrastructures and data present in the PENTA network. This would allow the Consortium participants to work together in a simplified and efficient manner that only could be assured by a solid administrative and technical structure set up to manage international research projects.